Evidence map›Paper›PMID 31545814›Full record

ArticlePloS one2019

Use of high-content analysis and machine learning to characterize complex microbial samples via morphological analysis.

Jennifer Petitte, Michael Doherty, Jacob Ladd, Cassandra L Marin, Samuel Siles, Vanessa Michelou, Amanda Damon, Erin Quattrini Eckert, Xiang Huang, John W Rice

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Seeing the bigger picture.Nature reviews. Microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jennifer PetitteNovozymes North America, Inc., Durham, North Carolina, United States of America.
Michael DohertyNovozymes North America, Inc., Durham, North Carolina, United States of America.ORCID 0000-0003-1498-9801
Jacob LaddNovozymes North America, Inc., Durham, North Carolina, United States of America.
Cassandra L MarinNovozymes North America, Inc., Durham, North Carolina, United States of America.
Samuel SilesNovozymes North America, Inc., Durham, North Carolina, United States of America.
Vanessa MichelouNovozymes North America, Inc., Durham, North Carolina, United States of America.ORCID 0000-0002-1379-4933
Amanda DamonNovozymes North America, Inc., Durham, North Carolina, United States of America.
Erin Quattrini EckertNovozymes North America, Inc., Durham, North Carolina, United States of America.
Xiang HuangNovozymes North America, Inc., Durham, North Carolina, United States of America.
John W RiceNovozymes North America, Inc., Durham, North Carolina, United States of America.ORCID 0000-0001-5713-5430

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High Content Analysis (HCA) has become a cornerstone of cellular analysis within the drug discovery industry. To expand the capabilities of HCA, we have applied the same analysis methods, validated in numerous mammalian cell models, to microbiology methodology. Image acquisition and analysis of various microbial samples, ranging from pure cultures to culture mixtures containing up to three different bacterial species, were quantified and identified using various machine learning processes. These HCA techniques allow for faster cell enumeration than standard agar-plating methods, identification of "viable but not plate culturable" microbe phenotype, classification of antibiotic treatment effects, and identification of individual microbial strains in mixed cultures. These methods greatly expand the utility of HCA methods and automate tedious and low-throughput standard microbiological methods.

Indexed as

Machine LearningAnti-Bacterial AgentsBacillus megateriumBacteriaBacterial ProteinsBradyrhizobiumColony Count, MicrobialEscherichia coliPseudomonas fluorescensAnti-Bacterial AgentsBacterial Proteins

Identifiers

PMID31545814
PMCPMC6756541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.